Wednesday, August 19

Browsing: loyalty

Mental Health

Psychology says people who save loyalty points but rarely use them may value having options more than immediate rewards

By healthylife7August 19, 20260

Psychology says people who save loyalty points but rarely use them may value having options more than immediate rewards Psychology says people who save loyalty points but rarely use them may value having options more than immediate rewards possibility of a future reward open By Aastha Raj, Global Desk Aug 19, 2026, 04:20:00 PM IST…

Wellness Tips

Enveda clears Phase I with exercise-inspired pill targeting post-GLP

By healthylife7August 19, 20260

Boulder, Colorado-based Enveda has reported Phase I results for ENV-308, an oral small molecule designed to mimic Lac-Phe, a hormone the body produces during high-intensity exercise, positioning the drug as a potential maintenance therapy for patients who discontinue GLP-1 receptor agonists and subsequently regain weight

What's Hot

Enveda clears Phase I with exercise-inspired pill targeting post-GLP

Vermont Teens Report Better Wellbeing

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

Browsing: loyalty

Psychology says people who save loyalty points but rarely use them may value having options more than immediate rewards

Enveda clears Phase I with exercise-inspired pill targeting post-GLP

Vermont Teens Report Better Wellbeing

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

Hims & Hers Health (HIMS) Adds AI Weight Loss Care And Smart Scale

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

Enveda clears Phase I with exercise-inspired pill targeting post-GLP

Vermont Teens Report Better Wellbeing

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Browsing: loyalty